Women’s health testing: a guide for you
References
1 Vachani, C. 2005. HPV and cervical cancer. OncoLink (Abramson Cancer
Center of the University of Pennsylvania) URL: http://www.oncolink.com/types/article.cfm?c=6&s=17&ss=131&id=9531
(accessed 05.16.06).
2 White, W., et al. 1998. In vitro infection and type-restricted
antibody-mediated neutralization of authentic human papillomavirus Type 16. J. Virol.,
72 (2), URL: http://www.pubmedcentral.gov/articlerender.fcgi?artid=124566
(accessed 05.16.06).
3 American College of Obstetricians and Gynecologists Office of Communications.
05.09.2006. Press Release: ACOG recommends first ob-gyn visit in early teens. http://www.acog.org/from_home/publications/press_releases/nr05-09-06-2.cfm
(accessed 05.30.2006).
The American College of Obstetrics & Gynecologists Committee on Adolescent Health.
2006. ACOG Committee Opinion No. 335: The initial reproductive health visit. Ob.
& Gyn. 107 (5), 1215–1219.
Further reading
American Society for Colposcopy and Cervical Pathology (ASCCP): http://www.asccp.org/
American College of Gynecology (ACOG):
http://www.acog.org/
Hudson, T. 2001. Preventing and treating cervical dysplasia: a natural medicine
perspective. Alt. Comp. Therapies, 7 (1), 15–20.
National Cancer Institute. 2005. Vaccine protects against virus linked to
half of all cervical cancers. URL: http://www.cancer.gov/clinicaltrials/results/cervical-cancer-vaccine1102
Sattler, C. 2005. Efficacy of a prophylactic quadrivalent human papillomavirus (HPV)
(Types 6, 11, 16, 18) L1 virus-like particle (VLP) vaccine for prevention of cervical
dysplasia and external genital lesions (EGL). 45th Annual Interscience Conference
on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC.
Wright, T., et alia. Revised 2003. 2001 Concensus guidelines for the management
of women with cervical intraepithelial neoplasia. Am. J. Ob. Gyn. 189 (1),
295–304.
Return to:
Abnormal pap smears and HPV
Last Modified Date: 04/29/2011